miR-370 modulates insulin receptor substrate-1 expression and inhibits the tumor phenotypes of oral carcinoma

Oral Diseases

Volumn 19, Issue 6, 2013, Pages 611-619

  Chang, K W ^a,b   Chu, T H ^a   Gong, N R ^a   Chiang, W F ^a,c   Yang, C C ^a,b   Liu, C J ^a,d   Wu, C H ^a,b   Lin, S C ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

^d MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Carcinoma; IRS 1; miR 370; Mouth

Indexed keywords

INSULIN RECEPTOR SUBSTRATE 1; MICRORNA; MIRNA 370; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CELL MIGRATION; DOWN REGULATION; HUMAN; HUMAN CELL; KERATINOCYTE; MOUTH SQUAMOUS CELL CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSIENT EXPRESSION;

CARCINOMA; IRS-1; MIR-370; MOUTH;

AZACITIDINE; CARCINOGENESIS; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL MOVEMENT; CELLS, CULTURED; DNA MODIFICATION METHYLASES; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; KERATINOCYTES; MICRORNAS; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; ONCOGENE PROTEIN V-AKT; RNA, SMALL INTERFERING; TOR SERINE-THREONINE KINASES;

EID: 84880264012     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12046     Document Type: Article

References (34)

1. Bandres E, Cubedo E, Agirre X et al (2006). Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 5: 29.
2. Buck E, Eyzaguirre A, Rosenfeld-Franklin M et al (2008). Feedback mechanisms promote cooperativity for small molecule inhibitors of epidermal and insulin-like growth factor receptors. Cancer Res 68: 8322-8332.
3. Castilla MA, Moreno-Bueno G, Romero-Perez L et al (2011). Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma. J Pathol 223: 72-80.
4. Chen Z, Jin Y, Yu D et al (2012). Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma. Oral Oncol 48: 686-691.
5. Chiang WF, Hung PS, Liu SY et al (2011). Increase of ZASC1 gene copy number in recurrent oral carcinoma. Oral Dis 17: 53-59.
6. Childs G, Fazzari M, Kung G et al (2009). Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am J Pathol 174: 736-745.
7. Dixon-McIver A, East P, Mein CA et al (2008). Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. PLoS ONE 3: e2141.
8. Gaur A, Jewell DA, Liang Y et al (2007). Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 67: 2456-2468.
9. Goutzanis L, Vairaktaris E, Yapijakis C et al (2007). Diabetes may increase risk for oral cancer through the insulin receptor substrate-1 and focal adhesion kinase pathway. Oral Oncol 43: 165-173.
10. Haller F, von Heydebreck A, Zhang JD et al (2010). Localization- and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32.31. J Pathol 220: 71-86.
11. Houghton AM, Rzymkiewicz DM, Ji H et al (2010). Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat Med 16: 219-223.
12. Hung PS, Kao SY, Shih YH et al (2008). Insulin-like growth factor binding protein-5 (IGFBP-5) suppresses the tumourigenesis of head and neck squamous cell carcinoma. J Pathol 214: 368-376.
13. Hung PS, Chang KW, Kao SY, Chu TH, Liu CJ, Lin SC (2012). Association between the rs2910164 polymorphism in pre-mir-146a and oral carcinoma progression. Oral Oncol 48: 404-408.
14. Iliopoulos D, Drosatos K, Hiyama Y, Goldberg IJ, Zannis VI (2010). MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J Lipid Res 51: 1513-1523.
15. Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J (2008). Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 68: 2094-2105.
16. Lajer CB, Garnaes E, Friis-Hansen L et al (2012). The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer. Br J Cancer 106: 1526-1534.
17. Liu CJ, Tsai MM, Hung PS et al (2010). miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. Cancer Res 70: 1635-1644.
18. Lo WL, Yu CC, Chiou GY et al (2011). MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells. J Pathol 223: 482-495.
19. Lo SS, Hung PS, Chen JH et al (2012). Overexpression of miR-370 and downregulation of its novel target TGFbeta-RII contribute to the progression of gastric carcinoma. Oncogene 31: 226-237.
20. Meng F, Wehbe-Janek H, Henson R, Smith H, Patel T (2008). Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes. Oncogene 27: 378-386.
21. Metz HE, Houghton AM (2011). Insulin receptor substrate regulation of phosphoinositide 3-kinase. Clin Cancer Res 17: 206-211.
22. Moore KJ, Rayner KJ, Suarez Y, Fernandez-Hernando C (2010). microRNAs and cholesterol metabolism. Trends Endocrinol Metab 21: 699-706.
23. Nehrbass D, Klimek F, Bannasch P (1998). Overexpression of insulin receptor substrate-1 emerges early in hepatocarcinogenesis and elicits preneoplastic hepatic glycogenosis. Am J Pathol 152: 341-345.
24. Ozes ON, Akca H, Mayo LD et al (2001). A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proc Natl Acad Sci U S A 98: 4640-4645.
25. Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL, Visakorpi T (2007). MicroRNA expression profiling in prostate cancer. Cancer Res 67: 6130-6135.
26. Reiss K, Del Valle L, Lassak A, Trojanek J (2012). Nuclear IRS-1 and cancer. J Cell Physiol 227: 2992-3000.
27. Sartor MA, Dolinoy DC, Jones TR et al (2011). Genome-wide methylation and expression differences in HPV(+) and HPV(-) squamous cell carcinoma cell lines are consistent with divergent mechanisms of carcinogenesis. Epigenetics 6: 777-787.
28. Selaru FM, Olaru AV, Kan T et al (2009). MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. Hepatology 49: 1595-1601.
29. Shi B, Sepp-Lorenzino L, Prisco M, Linsley P, deAngelis T, Baserga R (2007). Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells. J Biol Chem 282: 32582-32590.
30. Tanaka S, Wands JR (1996). A carboxy-terminal truncated insulin receptor substrate-1 dominant negative protein reverses the human hepatocellular carcinoma malignant phenotype. J Clin Invest 98: 2100-2108.
31. Tran N, O'Brien CJ, Clark J, Rose B (2010). Potential role of micro-RNAs in head and neck tumorigenesis. Head Neck 32: 1099-1111.
32. Varnholt H, Drebber U, Schulze F et al (2008). MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology 47: 1223-1232.
33. Wu CH, Wu TY, Li CC, Lui MT, Chang KW, Kao SY (2010). Impact of diabetes mellitus on the prognosis of patients with oral squamous cell carcinoma: a retrospective cohort study. Ann Surg Oncol 17: 2175-2183.
34. Zhang J, Du YY, Lin YF et al (2008). The cell growth suppressor, mir-126, targets IRS-1. Biochem Biophys Res Commun 377: 136-140.